Abstract
I-Rationale of thrombolytic therapy in acute myocardial infarction (AMI). II-Thrombolytic drugs. III-Effects of thrombolytic therapy on mortality. IV-Studies comparing the effects of various thrombolytic agents on mortality.
MeSH terms
-
Clinical Trials as Topic
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Myocardial Infarction / drug therapy*
-
Myocardial Infarction / mortality
-
Streptokinase / therapeutic use
-
Thrombolytic Therapy*
-
Tissue Plasminogen Activator / therapeutic use
Substances
-
Fibrinolytic Agents
-
Streptokinase
-
Tissue Plasminogen Activator